CoreWeave Inc. CRWV
87.59
(2.54)
(2.82%)
as of 25 Sep
- Market cap
- $50.5B
- P/E
- 0.0×
Follow CRWV
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+7 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
15.82 | 6.07 | 6.56 | 7.23 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
40.34 | 19.98 | 13.68 | 80.78 | |
P/B ratio |
17.57 | 9.34 | 8.58 | 10.92 | |
Price to Tangible BV |
23.92 | 15.58 | 11.89 | 14.91 | |
EV/Sales |
18.49 | 9.50 | 10.09 | 11.03 | |
EV/EBITDA |
35.35 | 19.36 | 20.22 | 21.53 | |
EV/Operating CF |
47.24 | 15.94 | 10.51 | 12.11 | |
EV/FCF |
(9.88) | (6.72) | (5.92) | (6.13) | |
Quick Ratio |
0.43 | 0.43 | 0.29 | 0.43 | |
Current Ratio |
0.49 | 0.46 | 0.31 | 0.46 | |
Net Debt/EBITDA |
16.35 | 23.39 | 21.10 | 20.78 | |
Debt/Assets |
42.65% | 43.79% | 45.12% | 45.78% | |
Debt/Equity |
3.62 | 6.47 | 5.27 | 7.02 | |
Asset Turnover |
0.26 | 0.15 | 0.16 | 0.15 | |
Operating CF/Net income |
(15.34) | (3.44) | (4.03) | (1.08) | |
Capex/Depreciation |
(3.67) | (4.82) | (6.48) | (4.47) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
14.40% | 12.88% | 11.21% | 9.24% | |
Intangible Assets out of Total Assets |
0.03 | 0.03 | 0.02 | 0.02 | |
Share Based Compensation of Revenue |
10.58% | 9.96% | 7.36% | 6.41% | |
Graham Net Nets |
(0.36) | (1.24) | (1.11) | (1.14) | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(1.71%) | (4.34%) | (4.01%) | (3.67%) | |
Free Cash Flow Yield |
(11.83%) | (23.28%) | (26.00%) | (24.90%) | |
Revenue per Share |
2.74 | 3.61 | 3.94 | 4.67 | |
Operating CF per Share |
3.39 | 3.58 | 5.66 | 1.23 | |
Capex per Share |
(4.80) | (9.33) | (14.60) | (11.66) | |
Free Cash Flow per Share |
(1.41) | (5.75) | (8.94) | (10.42) | |
Cash per Share |
5.10 | 9.15 | 5.77 | 11.64 | |
Shareholders Equity per Share |
7.79 | 7.67 | 9.03 | 9.12 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
7.79 | 7.67 | 9.03 | 9.12 | |
Free Cash Flow |
(700.19) | (2,500.81) | (4,711.00) | (5,743.00) | |
Working Capital |
(4,983.59) | (8,952.00) | (12,209.00) | (11,397.00) | |
Capital Expenditures |
(2,389.24) | (4,059.76) | (7,695.00) | (6,422.00) | |
Net Current Asset Value |
(24,301.20) | (38,479.00) | (45,205.00) | (62,526.00) | |
EV/EBIT |
509.92 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
1.75 | 2.58 | 3.70 | 2.49 | |
Net Profit Margin |
(8.07%) | (28.80%) | (35.61%) | (24.31%) | |
Price to Operating Income |
436.30 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
— | 1,793.00 | 1,587.60 | 2,237.35 | |
Average Payables |
— | 1,245.50 | 2,306.55 | 2,429.79 | |
Average Assets |
16,455.25 | 33,567.50 | 38,716.69 | 51,655.68 | |
Average Common Equity |
— | 1,460.50 | 3,332.56 | 3,840.82 |
Columns are period end dates